Snoring and obstructive sleep apnoea (OSA) represent two prevalent yet fundamentally distinct sleep disorders, differing significantly in their pathophysiology and clinical consequences. While snoring typically results from vibration of upper airway tissues, sleep apnoea involves recurrent respiratory pauses that can lead to serious systemic complications. Distinguishing snoring from obstructive sleep apnoea (OSA) is vital—Dr Arman Barfeie employs Mandibular Movement Analysis and 3D airway mapping to identify high-risk patients, ensuring prompt referral to London’s leading sleep clinics as part of integrated care pathways.
Dental interventions for these conditions encompass a spectrum from oral appliance therapy (OATs) to surgical procedures. Mandibular advancement devices (MADs) constitute first-line treatment for mild-to-moderate OSA and can reduce snoring incidence by 50%. Lifestyle modifications, including weight management, alcohol avoidance, and positional therapy, serve as important adjuncts in managing these conditions. The London Sleep Research Centre (2023) emphasises that customised MADs fabricated by dental professionals achieve superior patient compliance and therapeutic outcomes compared to over-the-counter alternatives.
The systemic ramifications of untreated sleep apnoea – including hypertension, cardiovascular disease, and metabolic disorders – underscore the importance of early intervention. This article provides a comprehensive analysis of the difference between snoring and sleep apnoea, current treatment modalities, and management strategies, equipping dental practitioners with essential knowledge in this evolving specialty.